Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Hold
2,086
0.12% 106
2026
Q1
$734K Hold
2,086
0.13% 102
2025
Q4
$683K Hold
2,086
0.13% 104
2025
Q3
$589K Sell
2,086
-1
-0% -$290 0.11% 110
2025
Q2
$583K Buy
2,087
+1
+0% +$283 0.12% 104
2025
Q1
$650K Hold
2,086
0.15% 91
2024
Q4
$544K Hold
2,086
0.13% 101
2024
Q3
$672K Hold
2,086
0.16% 87
2024
Q2
$652K Buy
2,086
+50
+2% +$14.7K 0.16% 80
2024
Q1
$579K Hold
2,036
0.15% 87
2023
Q4
$586K Hold
2,036
0.16% 90
2023
Q3
$547K Sell
2,036
-177
-8% -$44.2K 0.17% 84
2023
Q2
$491K Hold
2,213
0.14% 97
2023
Q1
$535K Hold
2,213
0.16% 91
2022
Q4
$581K Sell
2,213
-256
-10% -$68.6K 0.18% 81
2022
Q3
$557K Buy
2,469
+6
+0.2% +$1.45K 0.19% 86
2022
Q2
$599K Hold
2,463
0.2% 90
2022
Q1
$596K Hold
2,463
0.17% 96
2021
Q4
$554K Hold
2,463
0.15% 112
2021
Q3
$524K Sell
2,463
-55
-2% -$12.7K 0.15% 110
2021
Q2
$614K Hold
2,518
0.18% 102
2021
Q1
$627K Hold
2,518
0.2% 97
2020
Q4
$579K Hold
2,518
0.19% 93
2020
Q3
$582K Hold
2,518
0.21% 86
2020
Q2
$645K Sell
2,518
-32
-1% -$7.3K 0.26% 70
2020
Q1
$533K Sell
2,550
-194
-7% -$42.4K 0.25% 59
2019
Q4
$661K Hold
2,744
0.26% 52
2019
Q3
$531K Sell
2,744
-129
-4% -$24.8K 0.23% 58
2019
Q2
$524K Buy
2,873
+288
+11% +$51.6K 0.22% 58
2019
Q1
$491K Buy
2,585
+737
+40% +$141K 0.22% 56
2018
Q4
$360K Buy
+1,848
New +$361K 0.24% 60

Other funds holding AMGN

FLC Capital Advisors's AMGN Position: Q2 2026 in Review

FLC Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 2,086 shares worth $755K. The position accounts for 0.12% of the portfolio, ranked #106.

FLC Capital Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • FLC Capital Advisors held 2,086 shares of Amgen worth $755K as of Q2 2026.
  • FLC Capital Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.12% of FLC Capital Advisors's portfolio in Q2 2026, its #106 holding.
  • FLC Capital Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.